26004-Pancreatic Cancer-NA-1596

Pancreatic Cancer

A Phase Ia/Ib, Multicenter, Open-label, First-in-human Study of IBI343 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors

  • Details

ClinicalTrials.gov ID: NCT05458219
Diagnosis Type: NA
USOR Number:

  • Address


,
P:

Search by practice name, trial titles, indicators and specific disease types.